PL01.6.A Radiomics outperforms semantic features for prediction of response to stereotactic radiosurgery in brain metastases

نویسندگان

چکیده

Abstract Background Brain metastases show different patterns of contrast enhancement, potentially reflecting hypoxic and necrotic tumor regions with reduced radiosensitivity. An objective evaluation these might allow a prediction response to radiotherapy. We therefore investigated the potential MRI radiomics in comparison visual assessment semantic features predict early stereotactic radiosurgery patients brain metastases. Material Methods In this retrospective study, 150 308 from solid tumors (NSCLC 53% patients) treated by (single dose 17-20 Gy) were evaluated. The each metastasis (partial or complete remission vs. stabilization progression) was assessed within 180 days after radiosurgery. Patterns enhancement pre-treatment T1-weighted MR images either visually classified (homogenous, heterogeneous, ring-like) subjected analysis. Random forest models optimized cross-validation evaluated hold-out test data set (30% metastases). Results total, 221/308 (72%) responded optimal model comprised 10 outperformed solely based on (AUC, 0.71 0.56; accuracy, 69% 54%). diagnostic performance could be further improved combining resulting an AUC 0.74 accuracy 75% set. Conclusion developed allowed enhancement.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Stereotactic radiosurgery for brain metastases.

Worldwide, approximately 100,000 patients have undergone stereotactic radiosurgery for a variety of intracranial lesions, of which brain metastases represent the most common treatment indication. This article summarizes the major issues surrounding the management of brain metastases, and also analyzes 21 independent reports of Gamma Knife- or linear accelerator-based radiosurgery, representing ...

متن کامل

[Stereotactic radiosurgery and radiotherapy for brain metastases].

Brain metastases management is still controversial even though many trials are trying to define the respective roles of neurosurgery, whole-brain radiotherapy, single-dose stereotactic radiotherapy and fractionated stereotactic radiotherapy. In this article, we review data from trials that examine the role of radiosurgery and fractionated stereotactic radiotherapy in the management of brain met...

متن کامل

Whole Brain Radiotherapy Combined with Stereotactic Radiosurgery versus Stereotactic Radiosurgery Alone for Brain Metastases.

BACKGROUND The aim of this study was to evaluate the effect of whole brain radiotherapy (WBRT) combined with streotactic radiosurgery versus stereotactic radiosurgery (SRS) alone for patients with brain metastases. MATERIALS AND METHODS This was a retrospective study that evaluated the results of 46 patients treated for brain metastases at Dr. Abdurrahman Yurtaslan Ankara Oncology Training an...

متن کامل

Stereotactic Radiosurgery for Metastases in Eloquent Central Brain Locations.

BACKGROUND To examine stereotactic radiosurgery (SRS) following whole brain radiotherapy for metastases in eloquent, central brain locations: brainstem, thalamus, and basal ganglia. METHODS We conducted a retrospective review of patients with metastases in eloquent, central brain locations who were treated with SRS between January 2000 and April 2012. All patients had whole brain radiotherapy...

متن کامل

Non Tumor Perfusion Changes Following Stereotactic Radiosurgery to Brain Metastases

PURPOSE To evaluate early perfusion changes in normal tissue following stereotactic radiosurgery (SRS). METHODS Nineteen patients harboring twenty-two brain metastases treated with SRS were imaged with dynamic susceptibility magnetic resonance imaging (DSC MRI) at baseline, 1 week and 1 month post SRS. Relative cerebral blood volume and flow (rCBV and rCBF) ratios were evaluated outside of tu...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Neuro-oncology

سال: 2022

ISSN: ['1523-5866', '1522-8517']

DOI: https://doi.org/10.1093/neuonc/noac174.003